Search

everythinglearnresearchcommunity

for

Search:↓

A user is using a compounded hair loss treatment with 5% minoxidil, 0.005% finasteride, and 0.01% tretinoin but is experiencing issues with residue and greasiness. They are inquiring if using the treatment five times a week instead of daily will still be effective.

The conversation discusses switching from oral to topical treatments for hair loss, specifically using a mix of retinoic acid, finasteride, and minoxidil, after oral treatments like dutasteride and finasteride were ineffective. The user is concerned about the cost and potential impact of dandruff on the absorption of topical treatments.

A long-term finasteride user is considering switching to dutasteride due to hair loss progression. Users share experiences with switching, noting side effects and varying effectiveness, with some experiencing shedding and others maintaining their hairline.

The conversation discusses the use of topical minoxidil and finasteride for hair loss, with some users combining them with oral treatments. Users share their experiences and opinions on effectiveness, cost, and convenience, with mixed views on whether topical or oral applications are superior.

This conversation is about a user named "mr_mime125" who experienced results from using topical finasteride (0.1%) and minoxidil (5%) solution 1.5 ml twice a day for the first two months followed by just minoxidil (5%) 1 ml once a day in the last month, resulting in a drastic improvement to their hairline. Other users discussed their progress while asking questions and offering encouragement.

The user has been using topical minoxidil with other ingredients and oral finasteride, but its effectiveness has decreased. They are considering switching to oral minoxidil after experiencing side effects with dutasteride.

The conversation is about the timeline for Kintor's phase 3 trials for GT20029 and the potential release of the product in three years. It also mentions treatments like Minoxidil, finasteride, and RU58841.

The user has been using finasteride daily since 2020, dutasteride twice weekly since September, 2.5 mg oral minoxidil daily, microneedling monthly, and ketoconazole semi-often. They are feeling lost about their hair loss progress after one year on this regimen.

The user shared positive results after one year of using topical minoxidil and finasteride for hair loss, reporting no side effects and fuller hair. They recommend trying topical treatments over oral due to fewer side effects.

A user shared progress pictures after 50 days of using a compound with 10% minoxidil, 0.1% finasteride, and biotin, expressing satisfaction with the results. Another user commented positively on the progress.

The user experienced hair regrowth and thicker hair after using 5% topical minoxidil, 0.025% topical finasteride, and dermarolling weekly. Despite initial doubts and side effects from oral finasteride, the user received positive feedback on their progress.

GT20029 and KX826 are promising hair loss treatments, with GT20029 increasing hair count and KX826 showing significant results. KX826 may be a good alternative for those who can't use finasteride or dutasteride, though results vary.

The user has been using liposomal topical finasteride since late 2022, progressively increasing the dose, but DHT serum levels remain largely unchanged. Despite using finasteride, minoxidil, microneedling, and ketoconazole, hair condition has neither improved nor worsened.

The conversation discusses hair regrowth progress from November 2023 to April 2024 using 1mg finasteride, 5% minoxidil, and weekly dermarolling. The consensus is that there is some improvement and increased density, with expectations of further progress.

The user is using a regimen for hair loss that includes topical and oral minoxidil, finasteride, a Musley holistic formula, homemade oil, and scalp massages. They are questioning if there is any progress in hair regrowth.

Cosmo Pharmaceuticals has enrolled about 850 out of 1400 patients for their phase 3 clinical trials of clascoterone (Breezula) and claims to be on schedule. The conversation is about hair loss treatments.

A 22-year-old used oral finasteride from Costco and topical Kirkland minoxidil for 4-5 months to treat hair loss, resulting in significant hair regrowth and restored confidence. The "big 3" refers to minoxidil, finasteride, and microneedling as hair loss treatments.

The user experienced noticeable hair regrowth after three months of using topical minoxidil and finasteride, with no reported side effects. Other users discussed their experiences with similar treatments, including concerns about side effects and alternative options like dutasteride.

A user shared their positive experience with hair regrowth using 1mg finasteride and 5% topical minoxidil daily, showing significant improvement in hair density over six months. The conversation includes supportive comments and questions about the treatment details, such as whether finasteride was taken orally or topically and if microneedling was used.

The user is using Minoxidil, RU58841, CB-03-01, WAY-316606, Ketoconazole, MK-677, and derma stamping to treat hair loss and has noticed new hair growth, especially around the temples and hairline. They apply different treatments at various times of the day and have seen improvements in skin condition and body hair texture.

A 33-year-old woman shared her successful hair regrowth journey using topical Minoxidil 5% once daily, resulting in thicker hair and increased confidence. She avoided oral treatments like finasteride due to potential side effects and focused on consistent application of Minoxidil.

PP405, a potential hair loss treatment, is facing delays in releasing Phase 2 results, causing frustration among users who compare it to past failed treatments. Despite skepticism, some remain hopeful about PP405's future, while others discuss alternative treatments like Clascoterone and its expected market release.

The conversation is about finding places in the U.S. that offer dutasteride mesotherapy for hair loss. The user is seeking recommendations and success stories.

Comparing the effectiveness of minoxidil 5% and adenosine 0.75% for treating male androgenetic alopecia, and measuring patient satisfaction rate; results showed that adenosine is comparable to minoxidil but provides quicker results, however availability of products with adenosine is much less than those with minoxidil.

The user is considering combining 1mg oral finasteride with 0.1% topical finasteride due to reduced effectiveness after 5 years and is also using minoxidil twice daily. They previously tried dutasteride but stopped due to side effects and are hesitant to try RU58841.

Dutasteride and minoxidil show significant hair growth results after 3 months. Users express admiration and congratulate the progress.

A user shared their hair loss journey, showing improvement after starting finasteride, dutasteride, minoxidil 5%, and microneedling. They are curious about their degree of baldness and why their hair has thinned.

The user is pleased with their hair transplant results but is concerned about the vertex area. They use Minoxidil and finasteride daily and had the procedure at a clinic in Athens.

A 25-year-old with aggressive diffuse NW5 hair loss is using Minoxidil, oral Finasteride, RU58841, Ketoconazole, and dermastamping, experiencing slow progress and mental health struggles. Despite some visible regrowth, the user feels discouraged due to ongoing hair loss and is seeking reassurance and advice.

Clascoterone's European release is expected in Q4 2026, with FDA approval anticipated by mid-2027. The discussion includes questions about the approval timeline and potential acceleration due to unmet needs.